Author

Elena Xenofontos

Observed names: ELENA XENOPHONTOS, Xenofontos, Elena

Institution: Limassol General Hospital

Observed institutions: Cyprus University of Technology, University of Cologne, Limassol General Hospital

ORCID: 0000-0002-9379-5257

Observed ORCIDs: 0000-0002-9379-5257, 0009-0002-5422-0220

OpenAlex ID: A5023726308

Short‐course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy

2024 · Ralph Mösges, Esther Raskopf, et al. · Allergy · 21

Probing the formation of secondary minerals in the bioleaching reactions of chalcopyrite by Raman and FTIR microspectroscopy

2014 · Constantinos Varotsis, Chrystaleni Giangou, et al. · New Biotechnology · 4

Neurocysticercosis: the First Case Report in Cyprus

2025 · Aristos Aristodimou, CHRISANTHI EVANGELOU, et al. · Journal of the Egyptian Society of Parasitology · 2

Planning the hepatitis C virus elimination in Cyprus: A modeling study

2021 · Ilias Gountas, Ioanna Yiasemi, et al. · World Journal of Gastroenterology · 1

A case report of transverse myelitis in a young man with neurosyphilis: prikaz bolesnika

2026 · Aristos Aristodimou, Iliana Petridou, et al. · Infektološki glasnik

Acute mastoiditis caused by Klebsiella pneumoniae carbapenemase (KPC) producing bacteria – an atypical cause

2026 · Aristodimou, Aristos, Raptopoulos, Zacharias, et al. · PubMed Central

Aeromonas caviae: A rare case of hepatic abscess

2026 · Aristodimou, Aristos, Raptopoulos, Zacharias, et al. · PubMed Central

Myo-Pericarditis in the Context if MIS-A Syndrome: A Short Review Based on a Miscellaneous Case Following COVID-19 Infection

2024 · Maria Ioannou, Angeliki Mouzarou, et al. · Cardiology and cardiovascular research.

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergens shows long-term effects already after 2 years of treatment by inducing a significant immune response in birch pollen allergic patients

2023 · Esther Raskopf, Laura England, et al. · Journal of Allergy and Clinical Immunology

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe and well tolerated – data from 3 sequential trials

2023 · Silke Allekotte, Esther Raskopf, et al. · Journal of Allergy and Clinical Immunology

Mannan-conjugated birch pollen allergoids reduce the combined symptom and medication score in birch pollen allergic patients already in the first treatment year and further decreases with prolonged treatment duration

2023 · Laura England, Esther Raskopf, et al. · Journal of Allergy and Clinical Immunology

Works count: 12

Citation count: 28

H-index: 2

I10-index: 1